Study of LX1606 in Subjects With Symptomatic Carcinoid Syndrome
This study has been completed.
First Posted: April 15, 2010
Last Update Posted: May 3, 2016
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||No date given|
|Primary Completion Date:||February 2014 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Submission:||February 4, 2016|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Pavel M, Hörsch D, Caplin M, Ramage J, Seufferlein T, Valle J, Banks P, Lapuerta P, Sands A, Zambrowicz B, Fleming D, Wiedenmann B. Telotristat etiprate for carcinoid syndrome: a single-arm, multicenter trial. J Clin Endocrinol Metab. 2015 Apr;100(4):1511-9. doi: 10.1210/jc.2014-2247. Epub 2015 Jan 30.